David Ebersman

From Wikipedia, the free encyclopedia
Jump to: navigation, search

David Ebersman is an American businessman. He is currently the CEO of Lyra Health, having formerly held the position of CFO of Facebook. Facebook issued an initial public offering (IPO) of its stock on May 18, 2012.[1]

Early life[edit]

David Ebersman attended the Trinity School in New York City, graduating in 1987.[citation needed] He then went on to attend Brown University and graduated in June 1991 with a AB in International Relations and Economics.[2]

Career[edit]

Ebersman began his professional career at Oppenheimer & Co, Inc. in September 1991 as a Research Analyst. Ebersman left Oppenheimer & Co in February 1994 and began working for Genentech, working his way up to CFO by the time of his 2009 departure.

In September 2009, Ebersman joined Facebook as the company's Chief Financial Officer, hired in part because he had "public company experience".[3] Ebersman oversaw the initial public offering (IPO) of stock on May 18, 2012.[4]

He was succeeded by David Wehner, who assumed the position on June 1, 2014.

In May 2015, Ebersman announced the launch of Lyra Health, a health care company that sells technology and services to address mental health.[5][better source needed]

In July 2015, Ebersman was appointed to the board of SurveyMonkey.[6]

References[edit]

  1. ^ "Going Public: Key Developments in Facebook's IPO - ABC News". Abcnews.go.com. 2012-02-01. Retrieved 2012-05-22. 
  2. ^ David A. Ebersman. "David Ebersman: Executive Profile & Biography - Businessweek". Investing.businessweek.com. Retrieved 2012-05-22. 
  3. ^ "Facebook hires former Genentech exec as CFO". ZDNet. 2009-06-29. Retrieved 2012-05-22. 
  4. ^ "Going Public: Key Developments in Facebook's IPO - ABC News". Abcnews.go.com. 2012-02-01. Retrieved 2012-05-22. 
  5. ^ "Announcing Lyra Health". Retrieved 2015-06-20. 
  6. ^ "Sheryl Sandberg Joins SurveyMonkey’s Board". Retrieved 2015-07-06.